Method of detecting β-lactam antibiotic induced vancomycin resistant MRSA (BIVR)
Despite the fact that the combination of vancomycin and a β-lactam antibiotic are known to act synergistically on vancomycin-susceptible Staphylococcus aureus (VSSA), some MRSA have emerged showing antagonism to the combination of vancomycin and a β-lactam antibiotic. These MRSA are called β-lactam...
Saved in:
Published in | International journal of antimicrobial agents Vol. 23; no. 1; pp. 1 - 5 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Elsevier B.V
2004
Amsterdam Elsevier New York, NY |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Despite the fact that the combination of vancomycin and a β-lactam antibiotic are known to act synergistically on vancomycin-susceptible
Staphylococcus aureus (VSSA), some MRSA have emerged showing antagonism to the combination of vancomycin and a β-lactam antibiotic. These MRSA are called β-lactam antibiotic-induced vancomycin resistant MRSA (BIVR). A method based on this antagonistic phenomenon has been devised to detect BIVR strains. The method inhibits the VSSA strain but allows the BIVR strain to grow. Forty-six commercially available β-lactam antibiotics induced the vancomycin-resistance. Using this detection method, 717 MRSA clinical isolates obtained from eight institutes throughout Japan were thus screened and 6.3% of these were detected as BIVR when judged at 48
h. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0924-8579 1872-7913 |
DOI: | 10.1016/j.ijantimicag.2003.05.018 |